Abstract. The urinary excretion of the androgen metabolites aetiocholanolone (E) and androsterone (A) as well as DHEA, 11-hydroxy-androsterone and the cortisol metabolites 11-oxo-aetiocholanolone and 11-hydroxy\x=req-\ aetiocholanolone in normoprolactinaemic and hyperprolactinaemic male and female acromegalics was studied and compared with that of appropriate control groups. In addition several plasma hormones were also measured. The growth hormone level in the patient group varied from 10\p=n-\550 mU/l. The excretion of both 11\ x=r eq-\ hydroxy-androsterone and DHEA was normal. The excretion of androsterone had decreased, while aetiocholanolone and cortisol metabolite excretion had increased. The ratio between aetiocholanolone and androsterone (E/A) excretion was significantly increased in all patient groups, but no correlation was found between the growth hormone level and the E/A ratio. dihydroxy-5ß-androstan-17-one. DOHA = 11-hydroxy-androsterone: 3a,llß-dihydroxy5a-androstan-l 7-one. DHEA = dehydroepiandrosterone: 3ß-hydroxy-5-androstene-17-one.
criptine caused a decrease in the E/A ratio in patients with decreased growth hormone levels, but not in patients in whom the growth hormone level remained unchanged. After selective transsphenoidal removal of the pituitary adenoma the E/A ratio decreased significantly. The increased E/A ratio in untreated patients could not be attributed to eventual changes in plasma levels of cortisol, thyroxine, prolactin, testosterone or oestrogens. We therefore suggest that growth hormone is involved in androgen metabolism in acomegaly.
In man the major urinary metabolites of the androgens testosterone, DHEA and androstenedione are androsterone (A) and aetiocholanolone (E). Reduc¬ tion of the 5-position in the steroid molecule is controlled by several hormones. Glucocorticoids cause a relative increase in the 5ß metabolite excre¬ tion (Moolenaar & Van Seters 1971) and thyroxine causes elevated 5a metabolite excretion (Hellman et al. 1959) leading to a higher or lower E/A ratio, respectively.
Other factors which influence the E/A ratio are sex and age: females have higher E/A ratios than males and with increasing age a higher E/A ratio is found for both sexes (Zumoff et al. 1976 ; Deslypere et al. 1981 ). We found an increased E/A ratio for untreated patients wich clinically active acro¬ megaly. The aims of this study were to extend this new finding by investigating a larger group of patients and to determine the influence of medical and surgical therapy.
Design of the Study and Methods
Forty-three patients (24 males and 19 females) with clinically active acromegaly were used for basal studies. All patients showed elevated mean growth hormone (GH) levels (calculated from 4 fasting blood samples). Furthermore, the GH level failed to drop below 5 mU/1 during an oral 100 g glucose tolerance test. In addition, A = androsterone: 3a-hydroxy-5a-androstan-17-one. E = aetiocholanolone: 3a-hydroxy-5ß-androstan-17-one. 11 OF. = 11-oxo-aetiocholanolone: 3ct-hydroxy-5ß-androstane-11,17-dione. HOHE = 11-hydroxy-aetiocholanolone: 3 -11ß-dihydroxy-5ß-androstan-17-one. DOHA = 11-hydroxy-androsterone: 3a,llß-dihydroxy5a-androstan-l 7-one. DHEA = dehydroepiandrosterone: 3ß-hydroxy-5-androstene-17-one. free from bound hormone. The detection limit is 2 µg/l, the inter-assay coefficient of variation 10.6%.
Gas-liquid chromatography was performed according to Moolenaar & Van Seters (1971 (Strauch et al. 1977; Miller & Blyth 1952 There were no differences in the excretion of 11-hydroxy-androsterone and DHEA between the 6 patients groups and the control groups. The excretion of aetiocholanolone was higher for the patient groups, while the reverse was noted (with the exception of normoprolactinaemic male pa¬ tients older than 50 years) for androsterone excre¬ tion. The sum of the excretion of androsterone and aetiocholanolone, which reflects total andro¬ gen production, found for the various patient groups did not differ from that found for the respective control groups. The E/A ratio was in¬ creased in all patient groups, but no correlation was found between the GH level and the E/A ratio.
The excretion of 11-oxo-aetiocholanolone was in¬ creased in all patient groups. The excretion of 11-hydroxy-aetiocholanolone was normal in normo¬ prolactinaemic female acromegalics and was in¬ creased in all other patient groups. Because ele¬ vated urinary excretion of 11-oxo-aetiocholanol¬ one and 11-hydroxy-aetiocholanolone is also found in patients with Cushing's disease, the plasma cor¬ tisol rhythm was investigated in 20 patients with active acromegaly, including both hyperprolactin- (Roelfsema et al. 1979 ). The most sig¬ nificant finding was the decrease in the E/A ratio in responder patients (see Table 3 and Fig. 1) ; this was The data for the surgically treated patients are presented in Table 4 . One week after pituitary surgery the GH level had normalised in 10 out of 16 male patients and 4 out of 6 female patients. In the remaining patients the GH levels were still (slightly) elevated: for males the range was 5.3-24 mIJ/1, for females the levels were 20 and 28.8 mU/1. These patients therefore underwent pituitary irra¬ diation.
In male patients the excretion of androsterone increased significantly after surgery; furthermore a significant decrease was found for aetiocholanolone 18 months after surgery. The sum of andro¬ sterone and aetiocholanolone excretion was un¬ changed, but the ratio E/A had decreased signifi¬ cantly (see also Fig. 2 ). In addition, a slight decrease in the excretion of 11-oxo-aetiocholanolone and 11-hydroxy-androsterone was found 2 years after surgery. Plasma thyroxine and cortisol levels re¬ mained unchanged after surgery; however, the plasma testosterone levels increased significantly. Before surgery the mean testosterone level was 11.4 ± 1.4 nmol/1, 6 months after surgery the level had increased to 16.6+1.7 nmol/1 (P < 0.005), after 12 months it was 21.2 ± 2.8 nmol/1 (P < 0.02) and after 24 months 20.1 ± 2.0 nmol/1 (P < 0.001).
In female patients the E/A ratio decreased sig¬ nificantly, due mainly to a decrease in the excretion of aetiocholanolone. Although the excretion of androsterone increased in 4 out of 6 patients, the difference was not statistically significant. Plasma thyroxine and cortisol levels remained unchanged. Unfortunately, the plasma testosterone levels were not determined after surgery.
Discussion
We have demonstrated that patients with active acromegaly exhibit an increased E/A ratio, which is caused by an increase in the excretion of aetio¬ cholanolone and by a decrease in the excretion of androsterone. The other abnormality in this con¬ dition is the increase in the excretion of 11-oxoaetiocholanolone and 11-hydroxy-aetiocholanolone.
Other clinical conditions associated with an in¬ creased E/A ratio are Cushing's disease (Moolenaar and Van Seters 1971) , hypothyroidism (Hellman et al. 1959), advanced age (Zumoff et 1973) and anorexia nervosa (Fishman & Bradlow 1977 ).
The urinary steroid excretion pattern found with our gas-liquid chromatography system for Cushing's disease cannot be distinguished from that observed for acromegaly. In this respect it is relevant to mention that, although the majority of the cortisol metabolites are excreted as glucuronides of tetrahydrocortisol, tetrahydrocortisone, cortolone and cortol, a small part (about 3-5%) is excreted as 17-oxo-steroids, namely 11-oxo-aetiocholanolone and 11-hydroxy-aetiocholanolone (mainly in the form of glucuronide esters). There¬ fore the increased excretion of these cortisol me¬ tabolites is in accordance with the increased free cortisol excretion in acromegaly (Lindholm et al. 1980 ). On the other hand, the plasma cortisol rhythm was normal, as shown in this study, in con¬ trast to that reported for patients with Cushing's disease. The mechanism of the increased cortisol metabolite excretion is not known, but it may be attributed to an increased distribution volume and/ or an enhanced metabolic clearance rate, although direct evidence for either possibility is lacking. Even more puzzling is our finding that after satis¬ factory surgical treatment the excretion remained elevated.
None of our patients had subnormal thyroxine levels, took medication or consumed excessive amounts of ethanol, so it must be the acromegaly that is associated with the increased E/A ratio for urine. The question that must be asked is which hormone is responsible for the observed abnor¬ mality. Several (Charro et al. 1973; Lindholm et al. 1977; Roelfsema et al. 1979) and can be attributed to a decrease in sex hormone-binding globulin levels (De Moor et al. 1972 Bradlow et al. 1967 3) continuous infusion of GH (both human GH and rat TH), probably mimicking the acromegalie condition (i.e. a sustained increase in circulating GH levels), in¬ duced feminised hepatic steroid metabolism in intact male rats and gonadectomised hypophysec¬ tomised rats of both sexes (Mode et al. 1981 ), 4) recent evidence has been obtained that GH (from male and female rat pituitaries) and the feminishing factor are identical (Mode et al. 1983 ). In none of their studies was bromocriptine capable of preventing the induction of a feminised pattern (although in vivo plasma prolactin levels were sup¬ pressed below the detection limit); moreover infu¬ sion with rat prolactin had no effect on steroid metabolism (Mode et al. 1982 (Mode et al. 1981 (Mode et al. , 1982 .
Therefore complementary studies in man on the effects of infusion of synthetic GH may provide further insight into the dynamics of androgen metabolism.
